Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!
cash Insider: Strategiepapier - Liebeserklärung für den Schweizer Aktienmarkt aus London! Ein gutes 2026! SGS übernimmt Panacea Infosec in Indien mit 90 Mitarbeitern! Idorsia erhält Zulassung in Kanada für Blutdrucksenker Jeraygo! Avolta schliesst Rückkaufprogramm 2025 ab! BfS: Detailhandel November zu VJ nom. +1,3%, real +2,3% (kalenderb.)! BfS: Dienstleistungsumsätze Oktober +3,7% gg VJ!
Temenos: Renaissance Credit launches lending in the cloud – a first in West Africa » Report
JB Tracker-Zertifikat auf den 2012 Laggards Basket » Report
Novartis new two-year data with Certican® shows positive outcomes at 24 months in largest liver transplant trial to date » Report
SGS acquires the Ware Care Group, NL » Report
Alpiq führt Restrukturierungsprogramm weiter » Report
Novartis data show ACZ885 delivered rapid and strong symptom relief while reducing frequency of attacks in two periodic fever syndromes » Report
Zehnder: Verlangsamtes Umsatzwachstum und weiterhin hohe Investitionen » Report
Pargesa: Consolidated results 3Q 2012 (unaudited) » Report
Ein schönes Wochenende
Joint Press Release Board of Governors of the Federal Reserve System, Federal Deposit Insurance Corporation, Office of the Comptroller of the Currency: Agencies Provide Guidance on Regulatory Capital Rulemakings » Report
Neuemissionen ZKB Warrants » Report
Italian authorities lift precautionary hold on Novartis seasonal influenza vaccines » Report
IN ZEICHNUNG: JB Barrier Reverse Convertibles » Report
CREDIT SUISSE NEW ISSUE: 8 Warrants on UBS, 4 Call(s), 4 Put(s) » Report
UBS NEW ISSUE Stable Income & Full Upside: 5% p.a. CHF Kick-In GOAL with Participation on Nestlé, Roche, Zurich Insurance » Report
CREDIT SUISSE NEW ISSUE: 8 Warrants on Zurich Insurance Group, 4 Call(s), 4 Put(s) » Report
UBS issued a new 8.50% p.a. USD Early Redemption Kick-In GOAL on Worst of Nasdaq 100 / Russell 2000 / S&P 500 / S&P/TSE 60 (Valor 11406457) directly in the secondary market.
UBS issued a new 7.00% p.a. CHF Early Redemption Kick-In GOAL on Worst of Euro STOXX 50 / Nikkei 225 / SMI / S&P 500 (Valor 19946174) directly in the secondary market.
IN SUBSCRIPTION: JB Callable Multi Barrier Reverse Convertibles auf Versorger- und Goldminen-Aktien » Report
Credit Suisse: Products in Subscription » Report
Novartis announces update to company's Board of Directors to take effect in February 2013 » Report
Richemont: Changes to senior management » Report
Partners Group: Accelerated book built offering priced at CHF 183 per share allowing Partners Group founders to invest a minimum of CHF 300 million alongside clients and to materially increase the free float » Report
Richemont announces its unaudited consolidated results for the six month period ended 30 September 2012 » Report
“Novartis is focused on innovation to address unmet medical needs for patients,” said Joe Jimenez, CEO, at R&Dday » Report
Mario Draghi, President of the ECB: Introductory statement to the press conference » Report
Neuemission ZKB Strukturierte Produkte » Report
EZB PRESSEMITTEILUNG: Geldpolitische Beschlüsse » Report
Bank of England maintains Bank Rate at 0.5% and the size of the Asset Purchase Programme at £375 billion » Report
Zurich - News Release: Isabelle Welton appointed Group Chief Marketing Officer » Report
BLW - Die Bevölkerung steht zur Schweizer Landwirtschaft » Report
KOF/KOF Konjunkturumfragen vom Oktober: Schlechtere Geschäftslage bei Schweizer Unternehmen » Report
Nestlé opens first research and development centre in India » Report
Schweiz: UBS senkt BIP-Prognose 2013 auf 0,9% von 1,4% » Report
Swisscom: Neue Mobilfunkangebote sehr erfolgreich - Schweizer Geschäft insgesamt leicht rückläufig – höhere Investitionen – Fastweb auf Kurs » Report
Novartis future growth prospects secured by industry-leading pipeline, with more than 139 projects with 73 new compounds » Report
Swiss Re reports very strong net income of USD 2.2 billion for third quarter of 2012, driven by Property & Casualty Reinsurance and Admin Re® US sale » Report
Nobel Biocare reports improved profits in a declining market » Report
Kuoni: higher turnover and improved operating earnings in the first nine months of 2012 » Report
Groupe BCV: très bons résultats avec un bénéfice brut en hausse » Report